Tiny injected gel particles to help chronic lower back pain

Scientists at The University of Manchester believe injections of tiny sponge-like particles could provide an alternative to major surgery in the treatment of chronic lower back pain.

Dr Brian Saunders from The School of Materials and Professor Tony Freemont from The Faculty of Medical and Human Sciences have developed tiny gel particles that swell and stiffen when injected into a damaged area.

Investigations have revealed that degenerated animal intervertebral discs containing the injected 'microgels' regain their mechanical properties.

This development opens up the possibility of human patients being able to regain full mobility and flexibility after receiving spinal injections.

This would compare favourably with spinal fusion - a major surgical procedure with considerable recovery time for the patient, resulting in a significant loss of mobility at the fused and adjacent discs.

Degeneration of intervertebral discs causes holes in the load-bearing tissue of the disc, decreasing disc height and resulting in pain.

The microgel particles the research team have developed are like 'smart sponges' when dispersed in water.

The material is a fluid at a low pH - in other words, a low level of acidity - and can be injected through a syringe. It changes to a stiff gel at physiological pH values - that is, once it enters the body - due to absorption of water by the particles.

During their investigations, the research team injected the material into a damaged bovine intervertebral disc and increased the pH to biological levels by injecting an alkaline solution.

Professor Freemont, who works in the Division of Regenerative Medicine in the School of Medicine, said: "This research was motivated by the urgent need for a non-surgical method for repairing intervertebral discs.

"Our approach has the advantage of restoring spinal mobility whereas spinal fusion surgery results in a significant loss of mobility at the fused and adjacent discs."

Dr Saunders said: "Although we are encouraged by our findings, much work lies ahead to develop a viable non-surgical repair technology to replace spinal fusion as the standard surgical treatment for chronic lower back pain."

He added that future work will investigate biodegradable microgels that release additives to stimulate regeneration of intervertebral disc tissue.

The research was funded by the Engineering and Physical Sciences Research Council (EPSRC) and The University of Manchester Intellectual Property Ltd (UMIP).

Dr Saunders and Professor Freemont recently reported their findings in the online journal Soft Matter. They now hope to secure extra funding with a view to conducting clinical trials.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    The University of Manchester. (2019, June 19). Tiny injected gel particles to help chronic lower back pain. News-Medical. Retrieved on April 18, 2024 from https://www.news-medical.net/news/2007/03/21/22637.aspx.

  • MLA

    The University of Manchester. "Tiny injected gel particles to help chronic lower back pain". News-Medical. 18 April 2024. <https://www.news-medical.net/news/2007/03/21/22637.aspx>.

  • Chicago

    The University of Manchester. "Tiny injected gel particles to help chronic lower back pain". News-Medical. https://www.news-medical.net/news/2007/03/21/22637.aspx. (accessed April 18, 2024).

  • Harvard

    The University of Manchester. 2019. Tiny injected gel particles to help chronic lower back pain. News-Medical, viewed 18 April 2024, https://www.news-medical.net/news/2007/03/21/22637.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Mite-proof covers may reduce severity of asthma exacerbations in allergic children